CHEK2 and breast cancer: In the unselected breast cancer cohort, twelve CHEK2 p.(Asp438Tyr) carriers were identified (12/2003, 0.6%, P = 0.66, OR = 0.78, 95% CI = 0.34–1.80, Table 1).